FLANDREAU, SD — Federal health inspectors determined that residents at Riverview Healthcare Center experienced actual harm as a result of significant medication errors, according to findings from a complaint investigation completed on September 25, 2025. The facility, located in this small eastern South Dakota community, was cited for four deficiencies during the inspection, including a Severity Level G violation for pharmacy service failures — a classification indicating isolated incidents of actual harm that fall just below the threshold of immediate jeopardy.
[IMAGE]
Complaint Investigation Reveals Pharmacy Service Breakdown
The Centers for Medicare & Medicaid Services (CMS) dispatched inspectors to Riverview Healthcare Center following a formal complaint, triggering a focused investigation into care practices at the facility. What investigators found was a breakdown in one of the most fundamental safety systems in any healthcare setting: medication management.
Under federal regulatory tag F0760, inspectors documented that the facility failed to "ensure that residents are free from significant medication errors." This particular regulation exists as a core safeguard in the federal nursing home oversight framework, designed to protect some of the most medically vulnerable individuals in the healthcare system.
The distinction between a medication error and a significant medication error is important. Federal regulations define a significant medication error as one that causes the resident discomfort or jeopardizes health and safety. These are not minor documentation lapses or timing delays measured in minutes — they are errors with measurable clinical consequences.
The Severity Level G classification assigned to this deficiency places it in a particularly concerning category within the CMS enforcement framework. The CMS uses a grid system ranging from Level A (lowest) to Level L (highest) to categorize deficiencies based on their scope and severity. Level G indicates an isolated incident where actual harm occurred but did not rise to the level of immediate jeopardy. In practical terms, this means inspectors confirmed that at least one resident was harmed — not merely placed at risk — by the medication error.
Understanding the Federal Severity Classification
The CMS severity grid evaluates deficiencies along two dimensions: the scope of the problem (how many residents are affected) and the severity of the outcome (the level of harm). The four severity tiers are:
- Level 1: No actual harm, with potential for minimal harm - Level 2: No actual harm, with potential for more than minimal harm - Level 3: Actual harm that is not immediate jeopardy - Level 4: Immediate jeopardy to resident health or safety
Riverview Healthcare Center's Level G citation falls within Tier 3, confirming documented harm. While the "isolated" scope designation suggests the error affected a limited number of residents rather than representing a facility-wide pattern, the confirmation of actual harm elevates this finding well beyond a routine compliance issue.
Nationally, medication errors in nursing homes remain a persistent patient safety concern. Residents in long-term care facilities typically take multiple medications simultaneously — a practice known as polypharmacy — which creates an environment where the margin for error is narrow. Older adults process medications differently due to age-related changes in kidney function, liver metabolism, and body composition, meaning that errors in dosing, timing, drug selection, or administration route can produce outsized clinical effects.
What Medication Errors Look Like in Practice
While the specific details of the medication error at Riverview Healthcare Center are documented in the full inspection report, significant medication errors in nursing facilities generally fall into several recognized categories:
Wrong dose errors occur when a resident receives more or less medication than prescribed. In elderly patients, even small deviations from prescribed doses of blood thinners, cardiac medications, or insulin can produce dangerous physiological responses. An overdose of a blood pressure medication, for example, can cause dangerously low blood pressure, leading to falls, loss of consciousness, or organ damage.
Wrong medication errors involve administering a drug not prescribed to a particular resident. In facilities where multiple residents share common spaces and care staff manage dozens of medication schedules simultaneously, the risk of administering one resident's medication to another is a recognized hazard. This type of error can introduce drugs that interact harmfully with a resident's existing medication regimen or medical conditions.
Omission errors — failing to administer a prescribed medication — can be equally dangerous. Missing doses of seizure medications, for instance, can trigger breakthrough seizure activity. Skipped doses of antibiotics can allow infections to worsen or develop antibiotic resistance.
Wrong route or timing errors involve giving medication through an incorrect method (oral vs. injectable, for example) or at intervals that compromise therapeutic effectiveness or safety.
Each of these error types has well-documented potential to cause the kind of actual harm inspectors confirmed at Riverview Healthcare Center.
Four Total Deficiencies Identified
The medication error citation was one of four deficiencies identified during the September 2025 complaint investigation. While the pharmacy service failure under F0760 carried the most serious severity classification, the presence of multiple deficiencies during a single focused investigation raises questions about the facility's broader compliance posture.
Complaint investigations differ from standard annual surveys in that they are triggered by specific allegations rather than conducted on a routine schedule. Inspectors arriving for a complaint investigation are typically focused on the issues raised in the complaint, though they are required to investigate any additional concerns observed during their time in the facility. The identification of four separate deficiencies during what began as a targeted investigation suggests inspectors encountered problems beyond the original complaint.
Riverview Healthcare Center reported correcting the medication error deficiency by September 30, 2025 — just five days after the inspection concluded. This rapid correction timeline indicates the facility acknowledged the findings and implemented corrective measures. However, a reported date of correction represents the facility's own assertion that the problem has been addressed. CMS may conduct follow-up surveys to verify that corrections have been implemented and sustained.
Industry Standards for Medication Safety
Federal regulations require nursing facilities to maintain robust medication management systems that include multiple layers of protection against errors. These systems are expected to include:
Pharmacist review of each resident's medication regimen at least monthly, with the consulting pharmacist reporting any irregularities to the attending physician and the facility's director of nursing.
Qualified administration of medications only by licensed personnel who have verified the "five rights" of medication administration: the right patient, the right drug, the right dose, the right route, and the right time.
Proper documentation of all medications administered, including the time, dose, route, and any observed effects or reactions.
Error reporting systems that capture and analyze medication errors to identify patterns and prevent recurrence.
When these systems function correctly, they create redundant safeguards that catch errors before they reach residents. A Severity Level G citation for actual harm suggests that one or more of these protective layers failed at Riverview Healthcare Center.
Flandreau Facility's Correction Timeline
The facility's reported correction date of September 30, 2025, falls within the standard window that CMS typically allows for deficiency correction, depending on the severity and nature of the finding. For Severity Level G deficiencies involving actual harm, regulators generally expect swift corrective action, and a five-day turnaround suggests the facility responded with urgency.
Corrective action plans for medication errors typically include elements such as retraining of nursing staff on medication administration protocols, enhanced pharmacist oversight, implementation or revision of error-reporting procedures, and increased auditing of medication passes. The adequacy and sustainability of these measures will ultimately be evaluated during subsequent inspections.
What This Means for Residents and Families
For current and prospective residents of Riverview Healthcare Center and their families, the inspection findings provide important context for evaluating the facility's care quality. Medication management is widely considered one of the most critical indicators of overall nursing home safety, and a confirmed instance of actual harm represents a data point that warrants attention.
Families can access the complete inspection report, including detailed descriptions of each deficiency, through the CMS Care Compare website or by requesting records directly from the facility. South Dakota's Department of Health also maintains inspection records that provide additional context about the facility's compliance history over time.
The full inspection findings, including details on all four deficiencies cited during the September 2025 investigation, are available in the complete federal survey report for Riverview Healthcare Center.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Riverview Healthcare Center from 2025-09-25 including all violations, facility responses, and corrective action plans.